Key
liver functions, including protein synthesis, carbohydrate
metabolism, and detoxification, are performed by specific populations
of hepatocytes that are defined by their relative positions within
the liver lobules. On a molecular level, the functional heterogeneity
with periportal and pericentral phenotypes, so-called metabolic liver
zonation, is mainly established by a gradient of canonical Wnt signaling
activity. Since the relevant physiological cues are missing in in vitro liver models, they fail to reflect the functional
heterogeneity and thus lack many liver functions. We synthetically
re-engineered Wnt signaling in murine and human hepatocytes using
a doxycycline-dependent cassette for externally controlled digital
expression of stabilized β-catenin. Thereby, we achieved adjustable
mosaic-like activation of Wnt signaling in in vitro-cultured hepatocytes that was resistant to negative-feedback loops.
This allowed the establishment of long-term-stable periportal-like
and pericentral-like phenotypes that mimic the heterogeneity observed in vivo. The in vitro-zonated hepatocytes
show differential expression of drug-metabolizing enzymes and associated
differential toxicity and higher levels of autophagy. Furthermore,
recombinant adeno-associated virus and hepatitis C virus preferentially
transduce the pericentral-like zonation phenotype, suggesting a bias
of these viruses that has been unappreciated to date. These tightly
controlled in vivo-like systems will be important
for studies evaluating aspects of liver zonation and for the assessment
of drug toxicity for mouse and man.